All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

jobs

transportation

business

stock-market-news

retail-news

crypto

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

charlotte

detroit

columbus

austin

kansas-city

dallas

atlanta

washington-dc

nw-arkansas

boulder

chicago

indianapolis

nashville

richmond

houston

san-francisco

seattle

colorado-springs

boston

des-moines

salt-lake-city

philadelphia

denver

phoenix

new-orleans

miami

twin-cities

huntsville

raleigh

san-antonio

portland

san-diego

tampa-bay

cleveland

pittsburgh

axios-local

axios-pro

axios-live

the-axios-show

9am Health, a virtual provider for cardio-metabolic health, raised a $9.5 million Series A extension.

Why it matters: By 2030, nearly half of all Americans are projected to live with obesity or pre-diabetes.

Details: The round was led by The Cigna Group Ventures — an opportunistic get for the company, co-CEOs Anton Kittelberger and Frank Westermann tell Axios.

9am Health elected to pursue an extension raise now, rather than wait for a Series B, they say.

Existing investors 7wire Ventures, Define Ventures, Leaps by Bayer and Founders Fund also participated.

How it works: The San Diego-based startup offers both B2B and DTC cardio-metabolic care, providing personalized care plans, prescription delivery, at-home lab tests and access to specialists.

9am serves employers, PBMs, health systems and health plans to help deliver holistic treatment for diabetes, obesity, high cholesterol and hypertension.

The company is also partnered with Eli Lilly's telehealth offering LillyDirect, providing specialized care starting at $69 per month, with or without insurance coverage.

What's next: Fresh funds will help the company expand its internal team of care specialists and doctors.

Kittelberger and Westermann declined to comment on runway, profitability and financials, but they confirmed the company is generating revenue.

The big picture: The rise of interest in GLP-1s is a watershed moment, inspiring patients and physicians to manage diabetes and weight health better.

Yes, but: Those drugs are expensive and in short supply.

"The hefty price tag raises the stakes, demanding solutions for employers balancing cost constraints amid soaring expectations of their workforce," says Westermann.

Catch up quick: 9am Health raised its $16 million Series A in 2022.

State of play: Virtual diabetes management emerged as a major proof point for telehealth during COVID and startups continue to draw VC funds.

Metabolic care startup Twin Health received $50M in Series D funding last December.

Diabetes care provider Ryse Health drew $6.5 million in Series A funds last March.

Metabolic monitoring startup Levels, which offers biofeedback on how food impacts health, raised its $7 million Series A extension in January 2023.

⏰ 1 fun thing: The name 9amHealth reflects the idea that despite bad days of living with a chronic condition, each new day offers a chance for a new beginning.

9amHealth raises $9.5M extension for virtual metabolic care

By 2030, nearly half of all Americans are projected to live with obesity or pre-diabetes - 9amHealth is trying to cut that number down

Illustration of a phone wearing a doctor's coat and a stethoscope. 

Health tech deals

9am Health, a virtual provider for cardio-metabolic health, raised a $9.5 million Series A extension.Why it matters: By 2030, nearly half of all Americans are projected to live with <a class="gtmContentClick" data-vars-link-text="obesity" data-vars-click-url="https://streaklinks.com/B3AnBpJLy2v8es9fjAOO6GvD/https%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMsa1909301%3Fquery%3Dfeatured_home" data-vars-content-id="609ff3ec-3e2d-4117-843d-92ec849d645e" data-vars-headline="9amHealth raises $9.5M extension for virtual metabolic care" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://streaklinks.com/B3AnBpJLy2v8es9fjAOO6GvD/https%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMsa1909301%3Fquery%3Dfeatured_home" target="_blank">obesity</a> or pre-diabetes.

9amHealth raises $9.5M extension for virtual metabolic care

What to read next